BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

342 related articles for article (PubMed ID: 27846392)

  • 1. A Druggable TCF4- and BRD4-Dependent Transcriptional Network Sustains Malignancy in Blastic Plasmacytoid Dendritic Cell Neoplasm.
    Ceribelli M; Hou ZE; Kelly PN; Huang DW; Wright G; Ganapathi K; Evbuomwan MO; Pittaluga S; Shaffer AL; Marcucci G; Forman SJ; Xiao W; Guha R; Zhang X; Ferrer M; Chaperot L; Plumas J; Jaffe ES; Thomas CJ; Reizis B; Staudt LM
    Cancer Cell; 2016 Nov; 30(5):764-778. PubMed ID: 27846392
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Blastic Plasmacytoid Dendritic Cell Neoplasm.
    Khoury JD
    Curr Hematol Malig Rep; 2018 Dec; 13(6):477-483. PubMed ID: 30350260
    [TBL] [Abstract][Full Text] [Related]  

  • 3. New perspectives in genetics and targeted therapy for blastic plasmacytoid dendritic cell neoplasm.
    Zhang X; Sun J; Yang M; Wang L; Jin J
    Crit Rev Oncol Hematol; 2020 May; 149():102928. PubMed ID: 32234682
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dual Expression of TCF4 and CD123 Is Highly Sensitive and Specific For Blastic Plasmacytoid Dendritic Cell Neoplasm.
    Sukswai N; Aung PP; Yin CC; Li S; Wang W; Wang SA; Ortega V; Lyapichev K; Nagarajan P; Alfattal R; Angelova E; Tang Z; Loghavi S; Kanagal-Shamanna R; Miranda RN; Pemmaraju N; Bhalla K; Konopleva M; Medeiros LJ; Khoury JD
    Am J Surg Pathol; 2019 Oct; 43(10):1429-1437. PubMed ID: 31261288
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expanding the Immunophenotypic Spectrum of Neoplastic and Reactive Plasmacytoid Dendritic Cells.
    Wu SJ; Sadigh S; Lane AA; Pinkus GS
    Am J Clin Pathol; 2023 May; 159(5):455-463. PubMed ID: 36880313
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Recurrent 8q24 rearrangement in blastic plasmacytoid dendritic cell neoplasm: association with immunoblastoid cytomorphology, MYC expression, and drug response.
    Sakamoto K; Katayama R; Asaka R; Sakata S; Baba S; Nakasone H; Koike S; Tsuyama N; Dobashi A; Sasaki M; Ichinohasama R; Takakuwa E; Yamazaki R; Takizawa J; Maeda T; Narita M; Izutsu K; Kanda Y; Ohshima K; Takeuchi K
    Leukemia; 2018 Dec; 32(12):2590-2603. PubMed ID: 29795241
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Blastic Plasmacytoid Dendritic Cell Neoplasm: Progress in Cell Origin, Molecular Biology, Diagnostic Criteria and Therapeutic Approaches.
    Cheng W; Yu TT; Tang AP; He Young K; Yu L
    Curr Med Sci; 2021 Jun; 41(3):405-419. PubMed ID: 34218354
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Blastic Plasmacytoid Dendritic Cell Neoplasm Is Dependent on BCL2 and Sensitive to Venetoclax.
    Montero J; Stephansky J; Cai T; Griffin GK; Cabal-Hierro L; Togami K; Hogdal LJ; Galinsky I; Morgan EA; Aster JC; Davids MS; LeBoeuf NR; Stone RM; Konopleva M; Pemmaraju N; Letai A; Lane AA
    Cancer Discov; 2017 Feb; 7(2):156-164. PubMed ID: 27986708
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An Unexpected Chink in the Transcriptional Armor of Plasmacytoid Dendritic Neoplasms.
    Kleppe M; Levine RL
    Cancer Cell; 2016 Nov; 30(5):659-660. PubMed ID: 27846385
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genome-wide DNA methylation-analysis of blastic plasmacytoid dendritic cell neoplasm identifies distinct molecular features.
    Künstner A; Schwarting J; Witte HM; Xing P; Bernard V; Stölting S; Lohneis P; Janke F; Salehi M; Chen X; Kusch K; Sültmann H; Chteinberg E; Fischer A; Siebert R; von Bubnoff N; Merz H; Busch H; Feller AC; Gebauer N
    Leukemia; 2024 May; 38(5):1086-1098. PubMed ID: 38600314
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Whole-genome analysis uncovers recurrent IKZF1 inactivation and aberrant cell adhesion in blastic plasmacytoid dendritic cell neoplasm.
    Bastidas Torres AN; Cats D; Mei H; Fanoni D; Gliozzo J; Corti L; Paulli M; Vermeer MH; Willemze R; Berti E; Tensen CP
    Genes Chromosomes Cancer; 2020 May; 59(5):295-308. PubMed ID: 31846142
    [TBL] [Abstract][Full Text] [Related]  

  • 12. KMT2A (MLL)-MLLT1 rearrangement in blastic plasmacytoid dendritic cell neoplasm.
    Yang N; Huh J; Chung WS; Cho MS; Ryu KH; Chung HS
    Cancer Genet; 2015 Sep; 208(9):464-7. PubMed ID: 26164398
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Blastic plasmacytoid dendritic cell neoplasm: update on therapy especially novel agents.
    Wang S; Wang X; Liu M; Bai O
    Ann Hematol; 2018 Apr; 97(4):563-572. PubMed ID: 29455234
    [TBL] [Abstract][Full Text] [Related]  

  • 14. LXR agonist treatment of blastic plasmacytoid dendritic cell neoplasm restores cholesterol efflux and triggers apoptosis.
    Ceroi A; Masson D; Roggy A; Roumier C; Chagué C; Gauthier T; Philippe L; Lamarthée B; Angelot-Delettre F; Bonnefoy F; Perruche S; Biichle S; Preudhomme C; Macintyre E; Lagrost L; Garnache-Ottou F; Saas P
    Blood; 2016 Dec; 128(23):2694-2707. PubMed ID: 27702801
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Blastic plasmacytoid dendritic cell neoplasm: update on molecular biology, diagnosis, and therapy.
    Riaz W; Zhang L; Horna P; Sokol L
    Cancer Control; 2014 Oct; 21(4):279-89. PubMed ID: 25310209
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular Features of Blastic Plasmacytoid Dendritic Cell Neoplasm: DNA Mutations and Epigenetics.
    Sapienza MR; Pileri S
    Hematol Oncol Clin North Am; 2020 Jun; 34(3):511-521. PubMed ID: 32336416
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Blastic plasmacytoid dendritic cell neoplasm (BPDCN): a rare entity.
    Lim MS; Lemmert K; Enjeti A
    BMJ Case Rep; 2016 Jan; 2016():. PubMed ID: 26791132
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mutated ZRSR2 and CUL3 accelerate clonal evolution and confer venetoclax resistance via RAS signaling pathway in blastic plasmacytoid dendritic cell neoplasm.
    Fukuchi K; Koyama D; Takada M; Mori H; Hayashi K; Asano N; Sato Y; Fukatsu M; Takano M; Takahashi H; Shirado-Harada K; Kimura S; Yamamoto T; Ikezoe T
    Int J Hematol; 2023 Oct; 118(4):489-493. PubMed ID: 37029861
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Novel Therapeutic Approaches in Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN): Era of Targeted Therapy.
    Wilson NR; Konopleva M; Khoury JD; Pemmaraju N
    Clin Lymphoma Myeloma Leuk; 2021 Nov; 21(11):734-740. PubMed ID: 34226167
    [TBL] [Abstract][Full Text] [Related]  

  • 20. E-Cadherin Expression and Blunted Interferon Response in Blastic Plasmacytoid Dendritic Cell Neoplasm.
    Lorenzi L; Lonardi S; Vairo D; Bernardelli A; Tomaselli M; Bugatti M; Licini S; Arisi M; Cerroni L; Tucci A; Vermi W; Giliani SC; Facchetti F
    Am J Surg Pathol; 2021 Oct; 45(10):1428-1438. PubMed ID: 34081040
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.